Linagliptin-associated bullous pemphigoid treated with rituximab

Dipeptidyl peptidase 4 (DPP-4) inhibitors are increasingly used these days in management of diabetes. There has been reported in a few case reports of increasing association between DPP-4 inhibitor use and bullous pemphigoid (BP). We report a case of association between linagliptin use and BP and su...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:BMJ Case Rep
Autors principals: Mani, Hariharasudan, Safo, Patrick, Onitilo, Adedayo A
Format: Artigo
Idioma:Inglês
Publicat: BMJ Publishing Group 2019
Matèries:
Unexpected Outcome (Positive or Negative) Including Adverse Drug Reactions
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6768351/
https://ncbi.nlm.nih.gov/pubmed/31570343
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr-2019-229902
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars